Comparing the current results to its competitors, Evotec Se reported Revenue decrease in the 4 quarter 2025 year on year by -1.08 %, despite the revenue increase by the most of its competitors of 6.52 %, recorded in the same quarter.
Evotec Se's Comment on Competition and Industry Peers
Evotec operates a fully integrated drug discovery and development platform covering the entire value chain from discovery to early clinical development. The platform combines disease area expertise, comprehensive technology capabilities, and predictive tools across multiple modalities, including small molecules, biologics, and cell therapies, along with associated manufacturing capabilities. This approach contrasts with competitors that typically focus on specific segments within the value chain. Evotec utilizes proprietary technologies and a precision medicine platform aimed at enhancing research and development outcomes. The industry features rapid technological advancements, strong competition, and a complex intellectual property environment. Competitors identified in company filings include contract research organizations Wuxi Apptec and Charles River Laboratories; pharmaceutical R&D organizations; and companies specializing in PanOmics and patient-relevant disease modeling such as Recursion, Adaptive Biotechnologies, Sequantrix, Owkin, and Isomorphic.
Catalent Incs business model centers around offering comprehensive development and delivery solutions to pharmaceutical, biotechnology, and consumer health companies. By providing a diverse array of services such as drug development, manufacturing, packaging, and supply chain management, they aim to expedite the market entry of innovative and life-saving products for their clients.
Thermo Fisher Scientific Inc operates as a global leader in scientific research and services by delivering an extensive range of high-quality scientific instruments, reagents, consumables, and software solutions tailored to industries such as healthcare, pharmaceuticals, biotechnology, academia, and government. The company enhances its value proposition through a comprehensive suite of services, including laboratory outsourcing, scientific consulting, and data analysis, which help streamline research and development processes for its customers. By leveraging advanced technology and deep industry expertise, Thermo Fisher empowers researchers and organizations to drive innovation and accelerate scientific discovery.
Omniab Inc is a technology company that operates on a B2B (business-to-business) model, offering a range of software solutions and services. The company focuses on providing customized software applications to help businesses streamline their operations, enhance productivity, and improve efficiency. Omniab Inc also offers consultation services to assist companies in optimizing their IT infrastructure.
Charles River Laboratories International inc Share Performance
+82.61%
One Year
Charles River Laboratories International inc
Profile
Charles River Laboratories International Inc is a contract research organization (CRO) that provides essential services and support to the pharmaceutical, biotech, and medical device industries. They offer a wide range of research models, drug discovery and development services, safety assessments, and laboratory animal medicine to assist in the preclinical and clinical stages of drug development.
Sources:
Evotec Se’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Evotec Se versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
